NEW YORK (GenomeWeb News) —Hologic reported after the close of the market on Monday that fiscal first-quarter revenues declined 3 percent year over year, although its molecular diagnostic product sales helped mitigate this decline.

For the three months ended Dec. 28, 2013, Hologic's revenues totaled $612.4 million compared to $631.4 million a year ago, but besting the consensus Wall Street estimate of $609.7 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.